[Investor Updates]PharmAbcine, non-confidential slide deck Q4 2021

3 Dec 2021
제목PharmAbcine, non-confidential slide deck Q4 2021

Notice of Changes:

1. The introduction slides on company overview, core technologies, and main pipelines have been modified

2. The company’s long-term growth strategy slide has been added

3. Olinvacimab’s phase 2 mTNBC (metastatic Triple-Negative Breast Cancer) clinical design slide has been added

4. A market potential slide of PMC-403 in ophthalmology has been added

5. A slide on the PMC-309’s strengths in the current immuno-oncology market has been added

Please check the attached file for details.

Thank you for your continued support.

     2F, Research Building 2, 70,

     Yuseong-daero 1689 beon-gil,
     Yuseong-gu, Daejeon, 34047, Republic of Korea

     HQ +82-42-863-2017 

     R&D Center +82-42-861-2017

     Investor Relations +70-4294-6097 

     FAX +82-42-863-2080 

     COPYRIGHT BY PharmAbcine Inc.